Opendata, web and dolomites

CASI

AN INTEGRATED AUTOMATED ECG DIAGNOSTICS PLATFORM TO IMPROVE CARDIAC SAFETY IN CLINICAL DRUG TRIALS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CASI project word cloud

Explore the words cloud of the CASI project. It provides you a very rough idea of what is the project "CASI" about.

approvals    56m    time    totalling    successfully    renowned    operates    clinical    licensing    ip    world    customers    margin    delays    companies    fda    device    grown    revenue    mdd    company    50    algorithm    3rd    data    validate    anticipated    capacity    diagnostics    6bn    sells    ce    unnecessary    trials    certifications    market    ten    poor    minutes    purpose    customer    jpal    ecg    reducing    buying    jurisdictions    solutions    capability    designs    cardiac    mandated    algorithms    days    segment    participated    legislation    medical    vitalograph    drug    glasgow    university    regulated    regulatory    incorporating    entering    fits    consistency    70    ant    focusses    expensive    commercial    solution    strategy    few    safety    place    manufactures    pharmaceutical    services    cfda    dual    conducting    12    validation    cut    whilst    skills    25    party    automated    settings    bandwidth    group    csa    ago    introduce    heavily   

Project "CASI" data sheet

The following table provides information about the project.

Coordinator
VITALOGRAPH (IRELAND) LIMITED 

Organization address
address: MILL HOUSE HENRY STREET
city: LIMERICK
postcode: V94
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VITALOGRAPH (IRELAND) LIMITED IE (LIMERICK) coordinator 50˙000.00

Map

 Project objective

Vitalograph is a 50 year old company, that designs, manufactures and sells medical devices in clinical settings and clinical drug trials. This proposal focusses on the validation of a new dual-purpose 12 lead ECG diagnostics device incorporating an automated algorithm to be used in the regulatory mandated cardiac safety elements of clinical drug trials. Current solutions are expensive, introduce unnecessary analysis delays and have poor data consistency. The proposed solution can cut customer costs by 50% whilst at the same time improving Vitalograph’s margin from 25% to 70% as well as reducing the analysis time from several days to a few minutes. The target market has grown to be greater than €1.6Bn in 10 years with the targeted segment being one third of this. The target customers are pharmaceutical companies conducting drug trials The project fits well with Vitalograph’s product and market strategy to develop new medical devices for clinical drug trials and will increase the available market by a factor of 10. The company already operates successfully within the market having participated in over 50 trials totalling €56m in revenue since entering the market ten years ago. It has the R&D skills and bandwidth, operational capacity and commercial capability to fully exploit the resultant offering. Vitalograph has already established a market in cardiac safety in clinical trials by buying in other devices and services. Vitalograph will work with the world-renowned Glasgow University ECG group as a 3rd party to validate their existing clinical algorithms for automated use in clinical drug trials. An IP licensing agreement is already in place and no IP issues are anticipated. The market is heavily regulated under medical device legislation in all jurisdictions (CE MDD, FDA, CSA, JPAL, CFDA etc.) but Vitalograph already has the necessary approvals, experience, regulatory knowledge and certifications to bring this product to the market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CASI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CASI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HEADSpAcE (2019)

Translational studies of HEAD and neck cancer in South America and Europe

Read More  

cmRNAbone (2020)

3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More